The validation of new CHD1L inhibitors as a therapeutic strategy for cancer
Article in Biomedicine & Pharmacotherapy (December 2023)
The most recent citing publications are shown below. View all 47 publications that cite this research output on Dimensions.
DNA damage repair-related gene signature for identifying the immune status and predicting the prognosis of hepatocellular carcinoma
Article in Scientific Reports (November 2023)
The SIRT7-mediated deacetylation of CHD1L amplifies HIF-2α-dependent signal that drives renal cell carcinoma progression and sunitinib resistance
Article in Cell & Bioscience (September 2023)